110 related articles for article (PubMed ID: 12562214)
1. Targeting mature T cell leukemia: new understanding of molecular pathways.
Pekarsky Y; Hallas C; Croce CM
Am J Pharmacogenomics; 2003; 3(1):31-6. PubMed ID: 12562214
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of TCL1 causes T cell leukemia in mice.
Virgilio L; Lazzeri C; Bichi R; Nibu K; Narducci MG; Russo G; Rothstein JL; Croce CM
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3885-9. PubMed ID: 9520462
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of mature T-cell leukemia.
Pekarsky Y; Hallas C; Croce CM
JAMA; 2001 Nov; 286(18):2308-14. PubMed ID: 11710897
[TBL] [Abstract][Full Text] [Related]
4. The role of TCL1 in human T-cell leukemia.
Pekarsky Y; Hallas C; Croce CM
Oncogene; 2001 Sep; 20(40):5638-43. PubMed ID: 11607815
[TBL] [Abstract][Full Text] [Related]
5. Role of TCL1 and ALL1 in human leukemias and development.
Croce CM
Cancer Res; 1999 Apr; 59(7 Suppl):1778s-1783s. PubMed ID: 10197596
[TBL] [Abstract][Full Text] [Related]
6. TCL1 is overexpressed in patients affected by adult T-cell leukemias.
Narducci MG; Stoppacciaro A; Imada K; Uchiyama T; Virgilio L; Lazzeri C; Croce CM; Russo G
Cancer Res; 1997 Dec; 57(24):5452-6. PubMed ID: 9407948
[TBL] [Abstract][Full Text] [Related]
7. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Bichi R; Shinton SA; Martin ES; Koval A; Calin GA; Cesari R; Russo G; Hardy RR; Croce CM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6955-60. PubMed ID: 12011454
[TBL] [Abstract][Full Text] [Related]
8. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
Herling M; Patel KA; Teitell MA; Konopleva M; Ravandi F; Kobayashi R; Jones D
Blood; 2008 Jan; 111(1):328-37. PubMed ID: 17890451
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.
Pekarsky Y; Hallas C; Isobe M; Russo G; Croce CM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2949-51. PubMed ID: 10077617
[TBL] [Abstract][Full Text] [Related]
10. Expression of TCL1 in hematologic disorders.
Roos J; Hennig I; Schwaller J; Zbären J; Dummer R; Burg G; Tobler A; Virgilio L; Croce CM; Fey MF; Borisch B
Pathobiology; 2001; 69(2):59-66. PubMed ID: 11752899
[TBL] [Abstract][Full Text] [Related]
11. Comparison of karyotyping,
Sun Y; Tang G; Hu Z; Thakral B; Miranda RN; Medeiros LJ; Wang SA
J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581
[TBL] [Abstract][Full Text] [Related]
12. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.
Narducci MG; Virgilio L; Isobe M; Stoppacciaro A; Elli R; Fiorilli M; Carbonari M; Antonelli A; Chessa L; Croce CM; Russo G
Blood; 1995 Sep; 86(6):2358-64. PubMed ID: 7662982
[TBL] [Abstract][Full Text] [Related]
13. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia.
Brito-Babapulle V; Catovsky D
Cancer Genet Cytogenet; 1991 Aug; 55(1):1-9. PubMed ID: 1913594
[TBL] [Abstract][Full Text] [Related]
14. Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia.
Saitou M; Sugimoto J; Hatakeyama T; Russo G; Isobe M
Oncogene; 2000 May; 19(23):2796-802. PubMed ID: 10851082
[TBL] [Abstract][Full Text] [Related]
15. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract][Full Text] [Related]
16. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32).
Dürig J; Bug S; Klein-Hitpass L; Boes T; Jöns T; Martin-Subero JI; Harder L; Baudis M; Dührsen U; Siebert R
Leukemia; 2007 Oct; 21(10):2153-63. PubMed ID: 17713554
[TBL] [Abstract][Full Text] [Related]
17. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
Bresin A; Ragone G; Cristofoletti C; Arcelli D; Bassi C; Caprini E; Fiorenza MT; Helmer Citterich M; Russo G; Narducci MG
PLoS One; 2018; 13(10):e0204775. PubMed ID: 30286151
[TBL] [Abstract][Full Text] [Related]
18. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.
Takizawa J; Suzuki R; Kuroda H; Utsunomiya A; Kagami Y; Joh T; Aizawa Y; Ueda R; Seto M
Jpn J Cancer Res; 1998 Jul; 89(7):712-8. PubMed ID: 9738977
[TBL] [Abstract][Full Text] [Related]
19. Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo.
Hashimoto M; Suizu F; Tokuyama W; Noguchi H; Hirata N; Matsuda-Lennikov M; Edamura T; Masuzawa M; Gotoh N; Tanaka S; Noguchi M
Oncogenesis; 2013 Sep; 2(9):e70. PubMed ID: 24042734
[TBL] [Abstract][Full Text] [Related]
20. TCL1 is activated by chromosomal rearrangement or by hypomethylation.
Yuille MR; Condie A; Stone EM; Wilsher J; Bradshaw PS; Brooks L; Catovsky D
Genes Chromosomes Cancer; 2001 Apr; 30(4):336-41. PubMed ID: 11241786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
